CONTACT | Print Page | Sign In | Join
Coronavirus Disease (COVID-19) Resources
Share |

The coronavirus disease (COVID-19) is an infectious disease that causes severe acute respiratory illness and can spread among humans through respiratory transmission. Identified by the World Health Organization in December 2019, this worldwide concern has dictated a public health emergency.

BioFlorida recognizes the need to share important information involving COVID-19 with our members and the Community. Our Resource Center is updated regularly with the latest data, legislation and programs for businesses and research in the state, news about diagnostics, vaccines and therapeutics, and ways to contribute to the fight against COVID-19.



Biotechnology Innovation Organization (BIO)

Centers for Disease Control and Prevention (CDC)

Florida Department of Health (DOH)

World Health Organization


Centers for Disease Control and Prevention (CDC): Interim Guidance for Businesses and Employers

Florida Small Business Emergency Bridge Loan Program

Occupational Safety and Health Administration (OSHA): Guidance for Preparing Workplaces for Coronavirus

U.S. Chamber of Commerce: Resources & Guidelines for Business

U.S. Food and Drug Administration (FDA): Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

U.S. Small Business Administration (SBA): Small Business Guidance & Loan Resources

World Health Organization (WHO): Country & Technical Guidance



On behalf of the hospitals, healthcare systems, life sciences companies and thousands of healthcare workers of Florida, we are asking all life sciences and other organizations to consider how you may be able to help bring additional supplies and other resources to our healthcare institutions so they can continue to test and treat patients with COVID-19.
Attached via this link is a list of supplies and scientific and medical expertise we have collectively identified as most needed at this time. We ask you to share this list within your organizations, check your storerooms and supplies, and for those who have supplies / materials to sell or donate to the state, please use the Florida’s Department of Emergency Management (DEM) link to enter that information. The Florida DEM can be contacted at


national support of big pharma & MEDTECH companies

America’s biopharmaceutical companies are committed to developing solutions to help diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus. In addition to applying their scientific expertise to find ways to diagnose, treat and prevent infections from the virus, the biopharmaceutical industry is providing financial support and in-kind donations to organizations and collaborating with U.S. and global health authorities to combat this global public health emergency. More information. Source: PhRMA

Since the onset of the coronavirus (COVID-19) outbreak, AdvaMed member companies have donated millions of dollars’ worth of medical products and cash to hospitals, foundations and charities around the world. Medical device companies are responding to increased demand by ramping up production wherever possible, coordinating closely with governments to ensure the delivery of supplies where they are most needed, and in some cases, creating new devices and diagnostic tests to help effectively diagnose and treat sick patients. More information. Source: AdvaMed



ADMA Biologics, Inc. (Boca Raton)

AIM ImmunoTech Inc. (Ocala)

Akron Biotech (Boca Raton)


Arthrex (Naples)
ATOR Labs (Panama City Beach)
Biorep Technologies (Miami Lakes)

BioStem Technologies (Pompano Beach)
Biotest (Boca Raton)

Bristol Myers Squibb
Cantex Pharmaceuticals (Weston)
CSL Plasma (Boca Raton)
Entopsis (Medley)



Johnson & Johnson
Limbitless Solutions (Orlando)

Linical Americas (Stuart)

Lonza (Tampa)
Lumos Diagnostics (Sarasota)

Max Planck Florida Institute for Neuroscience (Jupiter)

Mayo Clinic (Jacksonville)
Noachis Terra (Gainesville)
Ology Bioservices (Alachua)
Oragenics (Tampa)
Organicell Regenerative Medicine (Miami)


Scripps Research (Jupiter)

Tampa General Hospital (Tampa)
Trividia Health, Inc. (Fort Lauderdale)

University of Miami (Miami)

Veloce BioPharma LLC (Fort Lauderdale)

STATE CONTACT:  Dayle Mooney (

Access Medical Laboratories (Jupiter)
ADPEN Laboratories, Inc. (Jacksonville)
Americanna Laboratories, LLC (Jacksonville)
Applied InGENuity Diagnostics (Orlando)
Boca Biolistics (Pompano Beach)
CBS Laboratories (Miami, Pompano Beach, Tampa)
CIC (Miami)
Dynix Diagnostix (Ft. Pierce)
Gene2genome LLC (Jacksonville)
Immunologix Laboratories (Tampa)
NCF Diagnostics & DNA Technologies (Alachua)
Longeveron LLC (Miami)
Mayo Clinic (Jacksonville)
Microgen DX (Orlando)
Nilogen Oncosystems (Tampa)
Vista Clinical Diagnostics (Clermont)




Partnerships, collaborations and coordination have never been more vital for Florida's life sciences industry. This has been a unique and challenging time for our businesses and personal lives. We are here to help!

To support the industry during this time, BioFlorida will offer member organizations that are hiring, Job Postings and Distribution of Job Postings to our database for no charge! We will waive all fees. This offer includes the Job Flash package only and is good until June 30, 2020.

Visit the Career Center to get setup and email for the coupon code to take advantage of this offer. (Good for the Job Flash Email package, a $440 value!)

We encourage all companies to take advantage of this offer and for Job Seekers to monitor the Job Board for opportunities that might be a good match for your skills.


Many of our members are using this time to rework their budgets or looks for cost savings solutions. Check out the 15 companies that BioFlorida member companies receive discounts on.

BioFlorida-Fisher Scientific Agreement Cost Savings & Benefits

  • Average discount of 55% off List Price
  • No Freight Charges on regular orders of laboratory consumables, supplies, PPE, equipment, life sciences tools and scientific instruments
  • BioFlorida 1st Year Membership Reimbursed in Product
  • High Volume Price List per customer for additional savings
  • Net 30-Day Payment Terms
  • Guaranteed $25,000 Initial Credit Line

Leasing available through Thermo Fisher Scientific Financial Service



September 15, 2020 OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients

September 9, 2020 Case study describes unexpected diagnosis of one of the first cases of MIS-C in U.S.

September 3, 2020 ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma

August 26, 2020 U.S. Army Contracting Command Awards Ology Bioservices Contract to Reserve Production Capacity in Support of Operation Warp Speed

August 23, 2020 Expanded Access Program for Convalescent Plasma discontinues enrollment as FDA authorizes its emergency use

August 12, 2020 Florida chosen for coronavirus vaccine test program run by the CDC

August 6, 2020 FDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy

August 4, 2020 AdvaMed’s National Testing Registry: Shipments of COVID-19 Molecular Diagnostic Tests Reach 100 Million

July 29, 2020 SMH Expands COVID-19 Antibody Cocktail Trial to People Recovering at Home

July 28, 2020 Hesperos demonstrates innovative Human-on-a-Chip® approach to modeling innate immune system response following tissue damage and acute inflammation

July 27, 2020 COVID vaccine study with 30,000 volunteers launched with Vice President Pence touting UM’s role in Miami

July 22, 2020 Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies

July 21, 2020 AdvaMed Unveils National Testing Registry to Aid in Fight Against COVID-19, Releases First Data Set

July 7, 2020 Governor DeSantis Extends State of Emergency in Florida

July 1, 2020 Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2

July 1, 2020
The FDA Updates Templates for Serology EUA Requests

June 30, 2020 GRDG Sciences and Chemia Corp. Announce 3F Biofragrance Success Against COVID-19

June 29, 2020 Cytocom, Inc. Announces Successful Completion of Type-B Pre-IND Meeting with FDA Regarding Proposed Phase 2 Clinical Trial of CYTO-201 in COVID-19 Patients

June 29, 2020 Gift Of Life Marrow Registry, Root, and Rutgers Researchers Launch Crowd Study Of Tissue Match Genes In COVID-19

June 17, 2020 Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency Guidance for Industry

June 12, 2020 Mutated coronavirus shows significant boost in infectivity

June 10, 2020 Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic's C1 Gene Expression Platform

June 4, 2020
Reopening Phase 2: Safe. Smart. Step-by-Step. Plan for Florida’s Recovery

June 4, 2020
Espero BioPharma, Inc. Expands Collaboration Effort for Tecarfarin

June 2, 2020 Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF- 100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress

June 1, 2020 Aspire Health Science Announces US FDA Approval of IND Application Regarding Testing Proprietary ACT-20 Cellular Therapy Against COVID-19 Pneumonia

June 1, 2020 FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients

May 29, 2020 Governor Ron DeSantis Announces Partnership with Home Depot and Publix to Open Six COVID-19 Testing Sites

May 26, 2020 Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801

May 21, 2020 ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

May 19, 2020 Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate

May 14, 2020 FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM

May 13, 2020 Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) 

May 7, 2020 CoVIg-19 Plasma Alliance Builds Strong Momentum Through Expanded Membership and Clinical Trial Collaboration

May 05, 2020
Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19

May 4, 2020 Oragenics Acquires Noachis Terra Inc., To Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”

May 1, 2020
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus

April 29, 2020 Chimerix, Exclusive Licensee of Cantex' Lead Product DSTAT, has Announced Initiation of a Phase 2/3 Study of DSTAT, Formerly Known as CX-01, in Acute Lung Injury for Patients with Severe COVID-19

April 29, 2020 Governor Announces Phase 1: Safe. Smart. Step-By-Step Plan for Florida’s Recovery

April 27, 2020 Coronavirus Florida: How Max Planck used its laser-cutting machinery to build face shields for first responders

April 24, 2020
SegAna Approved for COVID-19 Fastlane Project Pitch by National Science Foundation

April 23, 2020 Trividia Health, Inc. Announces Launch of SARS-COV-2 Antibody Test Kit

April 22, 2020 Ology Bioservices to Adapt Veroplex® Cell Platform for Rapid Response to Viral Threats for Department of Defense

April 21, 2020 North Naples-based Arthrex joins fight against COVID-19

April 21, 2020 FDA Authorizes First Test for Patient At-Home Sample Collection

April 20, 2020
Re-Open Florida Task Force Executive Committee Members Announced & Inaugural Meeting Held

April 20, 2020
Noachis Terra Inc., Developing a COVID-19 Vaccine, Announces Location of Headquarters in Gainesville, Florida

April 17, 2020 New Cell Therapy Trial Launches for Patients with Severe COVID-19

April 16, 2020 Tampa General Hospital Joins in National Research to Fight COVID-19

April 14, 2020 Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

April 7, 2020 Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S.

April 6, 2020 Global Plasma Leaders Collaborate To Accelerate Development of Potential COVID-19 Hyperimmune Therapy

April 3, 2020
Miami-Dade County Launches Nation’s Largest COVID-19 Screening Program with 15-Minute Blood Tests from Disaster Management Group

April 2, 2020 Prisma Health offers free device for ventilator-sharing through J&J partnership

April 2, 2020 Amgen Foundation to Donate $300,000 To United Way Suncoast, Hillsborough Education Foundation COVID-19 Efforts

April 1, 2020
Limbitless transitions to making face shield parts

March 30, 2020
Entopsis explores the use of its novel diagnostic platform, OpsisDxTM, for the detection of COVID-19 and triage of at-risk patients

March 26, 2020 Congress Passes CARES Act - 3rd Coronavirus Stimulus Bill

March 26, 2020
TherapeuticsMD Provides COVID-19-Related Business Update

March 25, 2020 Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus's Epidemiology

March 23, 2020 Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense

March 20, 2020 Governor Ron DeSantis Announces First Two Emergency Bridge Loans for Small Businesses Impacted by COVID-19

March 20, 2020 Scripps Research comes together to help combat the global pandemic

March 19, 2020 Ridgeback Biotherapeutics and Drug Innovations Ventures at Emory Partner to Develop Clinical Stage Coronavirus Treatment

March 18, 2020 Coronavirus (COVID-19) Update: FDA Issues Guidance for Conducting Clinical Trials

March 18, 2020 Medtronic Continuing to Increase Ventilator Production to Address COVID-19 Pandemic

March 18, 2020 WHO to launch multinational trial to jumpstart search for coronavirus drugs

March 18, 2020 Dyadic Presents New Business Opportunities to Address COVID-19, Influenza and Continued Scientific and Business Development Progress

March 16, 2020 Governor Ron DeSantis Activates Emergency Bridge Loan Program for Small Businesses Impacted by COVID-19

March 16, 2020 FDA quickly OKs its 2nd commercial COVID-19 test, from Thermo Fisher

March 16, 2020 TherapeuticsMD Provides Business Update on COVID-19 Pandemic

March 12, 2020 Governor DeSantis Activates Emergency Business Damage Assessment Survey for Coronavirus (COVID-19)

March 9, 2020 AIM ImmunoTech's Drug Ampligen to Be Tested by Japan's National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human Infectious Disease COVID-19

March 7, 2020 Governor Ron DeSantis Directs the Division of Emergency Management to Activate to Level II to Coordinate Statewide Response to COVID-19 in Florida

March 3, 2020 ADMA Biologics Highlights Expanded Intellectual Property Portfolio for Specialty Plasma Derived Immune Globulins Targeted Against Respiratory Infections

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 6,700 establishments and research organizations in the BioPharma, MedTech, HealthIT & BioAg that collectively employ nearly 94,000 Floridians.